Professor Angus Dalgleish

Angus Dalgleish is an Emeritus Professor of Oncology at St Georges, University of London and Principal of The Institute for Cancer Vaccines and Immunotherapy (ICVI). He qualified in medicine from University College and Hospital with an intercalated Hons BSc in Anatomy with Prof JZ Young, FRS. He spent one year as a flying doctor in Mt Isa, Australia, before joining the Physician training programme in Brisbane. Moving to Sydney to specialise in Oncology. He returned to the UK to study viruses and cancer with Professor Robin Weiss FRS at the ICR.

His research focused on the HIV receptor, pathogenesis and an effective vaccine candidate in collaboration with Bionor (Norway). Whilst working as an MRC senior Clinical research fellow he discovered that Thalidomide had major effects on the immune response which may be useful in HIV and Cancer. This led to a long-term collaboration with Celgene, resulting in the discovery of Lenalidomide and Pomalidomide, now licensed for myeloma and lymphoma worldwide with sales last year of 10 Billion dollars. For over 20 years he has researched cancer vaccines and immunotherapy for cancer and noted that Mycobacterium vaccae developed for TB corrected the immune deficiency seen in cancer patients. A subsequent development, now known as IMM-101, has shown activity in Melanoma and pancreatic cancer and is in trials for these conditions as well as COVID. As a result of these studies it became clear that good Vitamin D3 levels were vital for a clinical response and that several other agents have significant benefit in cancer patients, including LDN.

Dr Paul Marik

Dr Marik received his medical degree from the University of the Witwatersrand, Johannesburg, South Africa. He was an ICU attending at Baragwanath Hospital, in Soweto, South Africa. During this he obtained a Master of Medicine Degree, Bachelor of Science Degree in Pharmacology, Diploma in Anesthesia as well as a Diploma in Tropical Medicine and Hygiene. Dr Marik did a Critical Care Fellowship in London, Ontario, Canada, during which time he was admitted as a Fellow to the Royal College of Physicians and Surgeons of Canada.

Dr Marik has worked in various teaching hospitals in the US since 1992. He is board certified in Internal Medicine, Critical Care Medicine, Neurocritical Care and Nutrition Science. Until recently, Dr Marik was a tenured Professor of Medicine. Dr Marik has written over 500 peer reviewed journal articles, 80 book chapters and authored four critical care books and the Cancer Care Monograph. He has been cited over 57 000 times in peer-reviewed publications and has an H-index of 114. He has delivered over 350 lectures at international conferences and visiting professorships. He has received numerous teaching awards, including the National Teacher of the Year award by the American College of Physicians in 2017. Dr. Marik is the co-founder of the Front-Line Critical Care Alliance (FLCCC).

Dr Catherine Fyans

Dr Fyans was a medical practitioner for many years, working as an integrative medical practitioner for most of her career.

She has a long-standing interest in mind-body medicine and this led her to study a number of other healing disciplines aside from her conventional Western medical training. She enjoyed having a ‘foot in both worlds’ as this has gave her an insight into the spectrum of health care practices and health care consumer demands.

She has taken a keen interest in what has unfolded in the medical world since the pandemic was declared and views these times as opportunity to reassess, re-educate and reform our systems for the benefit of health care consumers and our communities at large.

Dr Fyans ‘retired’ from medical practice in 2021 to pursue her interests in mind-body consulting, trauma therapy and writing. Dr Fyans is the author of ‘The Wounding of Health Care – From Fragmentation to
Integration’.

Professor Ian Brighthope Dip.Ag.Sci., MB.BS., FACNEM.